CYTK enters the commercial stage with FDA-approved Myqorzo for oHCM, eyeing strong market share, but faces stiff competition and execution risks.
Researchers have found that amlodipine, a calcium-channel blocker prescribed to tens of millions of people for high blood pressure, can strip a key immune-evasion protein from the surface of cancer ...
Feeling constantly tired might have less to do with your schedule and more to do with what’s sitting in your medicine cabinet ...
Food does not affect Foundayo, so it can be taken with or without food. In contrast, oral Wegovy has to be taken on an empty stomach in the morning with up to four ounces of water. The package insert ...
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
Objective To investigate whether aligning exercise timing with chronotype enhances cardiometabolic and sleep-related benefits ...
Patients who start their blood pressure treatment with angiotensin receptor blocker (ARB) drugs continue with the same medicine to a greater extent than patients who start out with other drugs.
Researchers at Baylor College of Medicine have uncovered a previously unrecognized mechanism by which inherited calcium channel mutations disrupt early brain development and predispose children to ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ulixacaltamide HCl for the treatment of essential tremor in adults. Ulixacaltamid ...
A TWICE daily blood pressure tablet may help keep migraines at bay, research suggests. The drug prazosin, which is not ...
High blood pressure is the main modifiable risk factor for preventing cardiovascular events in people who have had a stroke or transient ischaemic attack; however, only approximately one in three ...
Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and mortality Currently available antiarrhythmic drugs (AADs) can be highly effective in acute cardioversion ...